TSC2 and tuberous sclerosis: For example, IL-6 is significantly upregulated and plays a critical role in the development of tuberous sclerosis complex, a benign tumor syndrome caused by aberrant mTORC1 activation due to the loss of either TSC1 or TSC2 [76].